Navigation Links
Fighting fire with fire: 'Vampire' bacteria has potential as living antibiotic
Date:10/31/2011

A vampire-like bacteria that leeches onto specific other bacteria including certain human pathogens has the potential to serve as a living antibiotic for a range of infectious diseases, a new study indicates.

The bacterium, Micavibrio aeruginosavorus, was discovered to inhabit wastewater nearly 30 years ago, but has not been extensively studied because it is difficult to culture and investigate using traditional microbiology techniques. However, biologists in the University of Virginia's College of Arts & Sciences, Martin Wu and graduate student Zhang Wang, have decoded its genome and are learning "how it makes its living," Wu said.

The bacterium "makes its living" by seeking out prey certain other bacteria and then attaching itself to its victim's cell wall and essentially sucking out nutrients. Unlike most other bacteria, which draw nutrients from their surroundings, M. aeruginosavorus can survive and propagate only by drawing its nutrition from specific prey bacteria. This kills the prey making it a potentially powerful agent for destroying pathogens.

One bacterium it targets is Pseudomonas aeruginosavorus, which is a chief cause of serious lung infections in cystic fibrosis patients.

"Pathologists may eventually be able to use this bacterium to fight fire with fire, so to speak, as a bacterium that will aggressively hunt for and attack certain other bacteria that are extremely harmful to humans," Wu said.

His study, detailing the DNA sequence of M. aeruginosavorus, is published online in the journal BMC Genomics [link: http://www.biomedcentral.com/1471-2164/12/453].It provides new insights to the predatory lifestyle of the bacterium and a better understanding of the evolution of bacterial predation in general.

"We used cutting-edge genomic technology in our lab to decode this bacterium's genome," Wu said. "We are particularly interested in the molecular mechanisms that allow it to hunt for and attack prey. This kind of investigation would have been extremely difficult and expensive to do only a few years ago."

He noted that overuse of traditional antibiotics, which work by either inhibiting bacteria propagation or interfering with cell wall formation, are creating so-called "super bugs" that have developed resistances to treatment strategies. He suggests that new approaches are needed for attacking pathogens without building up their resistance.

Additionally, because M. aeruginosavorus is so selective a feeder, it is harmless to the thousands of beneficial bacteria that dwell in the general environment and in the human body.

"It is possible that a living antibiotic such as M. aeruginosavorus because it so specifically targets certain pathogens could potentially reduce our dependence on traditional antibiotics and help mitigate the drug-resistance problem we are now facing," Wu said.

Another benefit of the bacterium is its ability to swim through viscous fluids, such as mucus. P. aeruginosavorus, the bacterium that colonizes the lungs of cystic fibrosis patients, creates a glue-like biofilm, enhancing its resistance to traditional antibiotics. Wu noted that the living cells of M. aeruginosavorus can swim through mucus and biofilm and attack P. aeruginosavorus.

M. aeruginosavorus also might have industrial uses, such as reducing bacteria that form biofilms in piping, and for medical devices, such as implants that are susceptible to the formation of biofilms.

Wu said M. aeruginosavorus requires further study for a more thorough understanding of its gene functions. He said genetic engineering would be required to tailor the predatory attributes of the bacterium to specific uses in the treatment of disease.

"We have a map now to work with, and we will see where it leads," he said.


'/>"/>
Contact: Fariss Samarrai
fls4f@virginia.edu
434-924-3778
University of Virginia
Source:Eurekalert

Related medicine news :

1. Fighting breast cancer early, one cell at a time
2. Fighting a smarter war against cancer
3. More evidence that allergies may help in fighting brain tumors
4. Stem cells, potential source of cancer-fighting T cells
5. Study linking gut microbe type with diet has implications for fighting GI disorders
6. Survivor Builds Cancer-Fighting House
7. Mouse Study Could Give New Clues to Fighting Baldness
8. Trial of Cancer-Fighting Virus Shows Promise
9. Rare immune cell is asset and liability in fighting infection
10. DOE laboratories help develop promising new cancer fighting drug, vemurafenib
11. Fighting breast cancer from new angles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... 05, 2016 , ... Pivot Point Consulting, a leading national ... & Services for HIT Implementation Support & Staffing report with an outstanding score ... by healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Colorize ... from on one drop zone to the next using Colorize's dynamic moving camera. Colorize ... project. This package includes a 3D slideshow environment with 1 to 5 focus points ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology: